BioCentury
ARTICLE | Financial News

Dynavax raises $132.2 million in follow-on

October 26, 2013 12:03 AM UTC

Dynavax Technologies Corp. (NASDAQ:DVAX) raised $132.2 million in a follow-on on Friday through the sale of 79.6 million common shares at $1.08 and 43,430 series B convertible preferred stock at $1,075. Each series B preferred stock converts into 1,000 shares of common stock. Cowen and William Blair are underwriters. Dynavax proposed the offering late Thursday, when its share price was $1.17. On Friday, the company was up $0.09 to $1.26. ...